Alexandria New Medical Center (EGX:AMES)

EGX:AMES Financials Overview

Financials in millions EGP. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	492.8	467.9	353.16	277.73	261.03	275.16
Revenue Growth	17.86%	32.49%	27.16%	6.40%	-5.13%	22.08%
Gross Profit Gross Profit Growth	151.15	146.62	101.54	63.19	74.16	100.99
Operating Income Operating Income Growth	65.93	68.1	32.73	9.54	10.57	47.17
Net Income Net Income Growth	53.61	55.04	29.82	5.93	-0.7	26.58
Earnings Per Share EPS Growth	0.43	0.44	0.24	0.05	-0.01	0.21
EPS Growth	19.09%	84.61%	402.63%	-	-	27.47%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Medicines and Medical Supplies Medicines and Medical Supplies Growth	146.92	143.17	112.88	85.02	87.8
Specialized Units Specialized Units Growth	101.15	94.02	66.93	65.67	50.81
Accommodation and Medical Supervision Accommodation and Medical Supervision Growth	89.72	87.62	67.43	41.05	44.57
Outpatient and Emergency Clinics Outpatient and Emergency Clinics Growth	70.47	67.15	50.68	38.71	34.46
Lab and X-Ray Lab and X-Ray Growth	63.4	56.27	37.51	32.42	31.04
Blood Bank Blood Bank Growth	18.79	18.06	16.28	13.61	10.27
Off-Site Services Off-Site Services Growth	2.36	1.61	1.44	1.26	2.08
Total Total Growth	492.8	467.9	353.16	277.73	261.03

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	43.51	41.1	34.81	41.52	53.58	66.13
Total Debt Total Debt Growth	20.9	15.52	35.18	-	6.48	18.21
Net Cash (Debt) Net Cash Growth	22.61	25.58	-0.37	41.52	47.1	47.92
Net Cash Growth	311.66%	-	-	-11.85%	-1.71%	621.72%
Net Cash Per Share Net Cash Per Share Growth	0.18	0.21	-0.00	0.33	0.38	0.38

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	18.13	21.09	26.51	-0.9	-0.42	54.46
Capital Expenditures CapEx Growth	-17.99	-20.51	-40.64	-14.07	-6.98	-13.78
Free Cash Flow Free Cash Flow Growth	0.14	0.58	-14.13	-14.97	-7.4	40.68
Free Cash Flow Growth	-	-	-	-	-	-4.02%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	30.67%	31.34%	28.75%	22.75%	28.41%	36.70%
Operating Margin	13.38%	14.56%	9.27%	3.44%	4.05%	17.14%
Pretax Margin	14.54%	15.69%	11.90%	5.06%	5.65%	16.50%
Profit Margin	10.88%	11.76%	8.44%	2.14%	-0.27%	9.66%
FCF Margin	0.03%	0.12%	-4.00%	-5.39%	-2.84%	14.78%

Dividends

Chart

Fiscal Year	FY 2021
Period Ending	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.100
Dividend Per Share Growth	-
Dividend Yield	2.87%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	342.51	124.73	77.17	154.36	-	31.95
P/FCF Ratio	131626.38	11917.45	-	-	-	20.88
PS Ratio	37.26	14.67	6.52	3.30	4.39	3.09

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 26, 2026

Data Sources Report a data error